PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-115

  1. 686 Posts.
    lightbulb Created with Sketch. 129
    Yes, on second reading you could well be right.
    At the same time, I do believe there are things afoot to right this ship. I just wish they didn't take so long.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.